Home | My NASDAQ | Tools | Mobile | Company List | ETFs | Pre-Market Quotes Real-Time Quotes After Hours Quotes
Home > Quotes > BIIB > Company News
BIIB
BIIB
$131.56
*
0.09
negative
0.07%

*Data as of May 25, 2012   | Biogen Idec Inc. | Industry: Health Care | HQ: Massachusetts, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 |  Sponsored

BIIB News Headlines

Share |


   


Biogen Tysabri Canadian Label Update - Analyst Blog
5/25/2012 5:44:01 PM - Zacks.com

AVEO's AV-203 in Phase I - Analyst Blog
5/24/2012 6:33:01 PM - Zacks.com

Biogen Says Health Canada Approves Updates To TYSABRI Product Monograph
5/23/2012 1:49:00 PM - RTT News

22 Biopharma Stocks With Breakout Potential in 2012
5/22/2012 8:56:00 AM - TheStreet

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan - Press Releases
5/21/2012 9:30:01 AM - Zacks.com

Data on Elan & Biogen's Tysabri - Analyst Blog
5/18/2012 4:41:01 PM - Zacks.com

WSJ BLOG/Health: New Caution Urged Over Sole Oral MS Drug On the Market
5/14/2012 5:45:00 PM - Dow Jones Business News

UPDATE: FDA Concludes Safety Review Of Novartis MS Drug Gilenya
5/14/2012 12:54:00 PM - Dow Jones Business News

Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's, Biogen Idec, Abbott, Novartis - Press Releases
5/14/2012 9:08:33 AM - Zacks.com

Biogen Idec: New AVONEX Dosing Innovations For MS Patients Now Available In US
5/14/2012 8:09:00 AM - RTT News

Standard Review for Biogen's BG-12 - Analyst Blog
5/11/2012 4:00:01 PM - Zacks.com

The ONLY Way You Should be Investing in Stocks Right Now
5/11/2012 10:00:00 AM - David Sterman

US,EU Regulatory Authorities Accept Oral BG-12 Marketing Applications For Review
5/9/2012 6:38:00 PM - RTT News

Isis Loss Widens on Higher Expenses - Analyst Blog
5/9/2012 1:00:01 PM - Zacks.com

Earnings Beat at PDL BioPharma - Analyst Blog
5/8/2012 1:15:15 PM - Zacks.com

Biogen Idec To Present At Deutsche Bank Conference; Webcast At 10:00 AM ET
5/8/2012 9:00:00 AM - RTT News

Revenues Climb at Acorda - Analyst Blog
5/4/2012 6:15:04 PM - Zacks.com

Markets End Well Off Highs But Dow Closes at Best Level Since December 2007
5/1/2012 4:30:00 PM - Knobias

Earnings Miss for Biogen - Analyst Blog
5/1/2012 2:50:01 PM - Zacks.com

Stocks Rally to Session Highs at Midday; Dow Hits Four-Year High
5/1/2012 1:28:00 PM - Knobias

2nd UPDATE: Biogen 1Q Profit Up, But Hurt By Purchasing Issue
5/1/2012 12:26:00 PM - Dow Jones Business News

UPDATE: Biogen 1Q Profit Up, But Hurt By Purchasing Issue
5/1/2012 10:54:00 AM - Dow Jones Business News

Stocks Move Higher in Early Trading on Positive Manufacturing Data
5/1/2012 10:36:00 AM - Knobias

Elan Misses 1Q EPS, Revenues Rise - Analyst Blog
5/1/2012 9:41:16 AM - Zacks.com

Futures Pointing to Modestly Higher Open for Markets
5/1/2012 9:11:00 AM - Knobias